BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 22136659)

  • 1. STAT3 activation in monocytes accelerates liver cancer progression.
    Wu WY; Li J; Wu ZS; Zhang CL; Meng XL
    BMC Cancer; 2011 Dec; 11():506. PubMed ID: 22136659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The STAT3 inhibitor NSC 74859 is effective in hepatocellular cancers with disrupted TGF-beta signaling.
    Lin L; Amin R; Gallicano GI; Glasgow E; Jogunoori W; Jessup JM; Zasloff M; Marshall JL; Shetty K; Johnson L; Mishra L; He AR
    Oncogene; 2009 Feb; 28(7):961-72. PubMed ID: 19137011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bile acids promote diethylnitrosamine-induced hepatocellular carcinoma via increased inflammatory signaling.
    Sun L; Beggs K; Borude P; Edwards G; Bhushan B; Walesky C; Roy N; Manley MW; Gunewardena S; O'Neil M; Li H; Apte U
    Am J Physiol Gastrointest Liver Physiol; 2016 Jul; 311(1):G91-G104. PubMed ID: 27151938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of suppressors of cytokine signaling 3 promotes aggressiveness in hepatocellular carcinoma.
    Wu WY; Kim H; Zhang CL; Meng XL; Wu ZS
    J Invest Surg; 2014 Aug; 27(4):197-204. PubMed ID: 24476004
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential role of signal transducer and activator of transcription (STAT)3 signaling pathway in inflammation, survival, proliferation and invasion of hepatocellular carcinoma.
    Subramaniam A; Shanmugam MK; Perumal E; Li F; Nachiyappan A; Dai X; Swamy SN; Ahn KS; Kumar AP; Tan BK; Hui KM; Sethi G
    Biochim Biophys Acta; 2013 Jan; 1835(1):46-60. PubMed ID: 23103770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NADPH Oxidase 1 in Liver Macrophages Promotes Inflammation and Tumor Development in Mice.
    Liang S; Ma HY; Zhong Z; Dhar D; Liu X; Xu J; Koyama Y; Nishio T; Karin D; Karin G; Mccubbin R; Zhang C; Hu R; Yang G; Chen L; Ganguly S; Lan T; Karin M; Kisseleva T; Brenner DA
    Gastroenterology; 2019 Mar; 156(4):1156-1172.e6. PubMed ID: 30445007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NSC 74859-mediated inhibition of STAT3 enhances the anti-proliferative activity of cetuximab in hepatocellular carcinoma.
    Chen W; Shen X; Xia X; Xu G; Ma T; Bai X; Liang T
    Liver Int; 2012 Jan; 32(1):70-7. PubMed ID: 22098470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hepatic leptin receptor expression can partially compensate for IL-6Rα deficiency in DEN-induced hepatocellular carcinoma.
    Mittenbühler MJ; Sprenger HG; Gruber S; Wunderlich CM; Kern L; Brüning JC; Wunderlich FT
    Mol Metab; 2018 Nov; 17():122-133. PubMed ID: 30224299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IL-6/STAT3 axis initiated CAFs via up-regulating TIMP-1 which was attenuated by acetylation of STAT3 induced by PCAF in HCC microenvironment.
    Zheng X; Xu M; Yao B; Wang C; Jia Y; Liu Q
    Cell Signal; 2016 Sep; 28(9):1314-1324. PubMed ID: 27297362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IL-6 promotes PD-L1 expression in monocytes and macrophages by decreasing protein tyrosine phosphatase receptor type O expression in human hepatocellular carcinoma.
    Zhang W; Liu Y; Yan Z; Yang H; Sun W; Yao Y; Chen Y; Jiang R
    J Immunother Cancer; 2020 Jun; 8(1):. PubMed ID: 32581055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NSC 74859 enhances doxorubicin cytotoxicity via inhibition of epithelial-mesenchymal transition in hepatocellular carcinoma cells.
    Hu QD; Chen W; Yan TL; Ma T; Chen CL; Liang C; Zhang Q; Xia XF; Liu H; Zhi X; Zheng XX; Bai XL; Yu XZ; Liang TB
    Cancer Lett; 2012 Dec; 325(2):207-13. PubMed ID: 22781398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth arrest and DNA damage 45G down-regulation contributes to Janus kinase/signal transducer and activator of transcription 3 activation and cellular senescence evasion in hepatocellular carcinoma.
    Zhang L; Yang Z; Ma A; Qu Y; Xia S; Xu D; Ge C; Qiu B; Xia Q; Li J; Liu Y
    Hepatology; 2014 Jan; 59(1):178-89. PubMed ID: 23897841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Total alkaloids of Rubus aleaefolius Poir. inhibit the STAT3 signaling pathway leading to suppression of proliferation and cell cycle arrest in a mouse model of hepatocellular carcinoma.
    Zhao J; Lin W; Cao Z; Liu L; Zhuang Q; Zhong X; Hong Z; Peng J
    Oncol Rep; 2013 Sep; 30(3):1309-14. PubMed ID: 23828071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CircSOD2 induced epigenetic alteration drives hepatocellular carcinoma progression through activating JAK2/STAT3 signaling pathway.
    Zhao Z; Song J; Tang B; Fang S; Zhang D; Zheng L; Wu F; Gao Y; Chen C; Hu X; Weng Q; Yang Y; Tu J; Ji J
    J Exp Clin Cancer Res; 2020 Nov; 39(1):259. PubMed ID: 33234142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anticancer activity of dietary xanthone α-mangostin against hepatocellular carcinoma by inhibition of STAT3 signaling via stabilization of SHP1.
    Zhang H; Tan YP; Zhao L; Wang L; Fu NJ; Zheng SP; Shen XF
    Cell Death Dis; 2020 Jan; 11(1):63. PubMed ID: 31980595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of growth and metastasis of human hepatocellular carcinoma by antisense oligonucleotide targeting signal transducer and activator of transcription 3.
    Li WC; Ye SL; Sun RX; Liu YK; Tang ZY; Kim Y; Karras JG; Zhang H
    Clin Cancer Res; 2006 Dec; 12(23):7140-8. PubMed ID: 17145839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Downregulation of protein disulfide‑isomerase A3 expression inhibits cell proliferation and induces apoptosis through STAT3 signaling in hepatocellular carcinoma.
    Kondo R; Ishino K; Wada R; Takata H; Peng WX; Kudo M; Kure S; Kaneya Y; Taniai N; Yoshida H; Naito Z
    Int J Oncol; 2019 Apr; 54(4):1409-1421. PubMed ID: 30720090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inactivation of p27kip1 promotes chemical hepatocarcinogenesis through enhancing inflammatory cytokine secretion and STAT3 signaling activation.
    Guo J; Ma Q; Zhou X; Fan P; Shan T; Miao D
    J Cell Physiol; 2013 Oct; 228(10):1967-76. PubMed ID: 23460367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DNMT3b/OCT4 expression confers sorafenib resistance and poor prognosis of hepatocellular carcinoma through IL-6/STAT3 regulation.
    Lai SC; Su YT; Chi CC; Kuo YC; Lee KF; Wu YC; Lan PC; Yang MH; Chang TS; Huang YH
    J Exp Clin Cancer Res; 2019 Nov; 38(1):474. PubMed ID: 31771617
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DJ-1 promotes development of DEN-induced hepatocellular carcinoma and proliferation of liver cancer cells.
    Qiu B; Wang J; Yu Y; Zhen C; Gu J; Liu W; Wen Y; Chen L; Gao Y; Xia Q; Kong X
    Oncotarget; 2017 Jan; 8(5):8499-8511. PubMed ID: 28036277
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.